Cough Frequency in Chronic Obstructive Pulmonary Disease

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Total Enrollment

24 participants

Study Classification

OBSERVATIONAL

Study Start Date

2012-01-31

Study Completion Date

2013-07-31

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

Acute exacerbations of COPD remain a common cause of morbidity and are associated with a sustained increase in the normal respiratory symptoms of dyspnoea, cough, and sputum volume and purulence. It has previously been shown that a change in cough symptoms occurs in 51.7% of exacerbations in COPD. We wish to record cough during a COPD exacerbation to determine whether this can be a objective marker of exacerbation duration and severity.

Related Clinical Trials

Explore similar clinical trials based on study characteristics and research focus.

Cough Monitoring in COPD

NCT07098793

Cough COPD COPD Exacerbation

COMPLETED

Phenotypic Measurements and Their Relation to Disease Exacerbation in COPD Patients

NCT03300739

COPD Exacerbation Copd

COMPLETED

An Observational Study Using Novel Questionnaire to Characterize Cough Phenotypes in Patients With Chronic Cough

NCT06376448

Chronic Cough

RECRUITING

Monitoring Coughs for the Early Detection of Worsening COPD

NCT07212439

Chronic Obstructive Pulmonary Disease (COPD)

RECRUITING

Respiratory Pathogens of Patients With Asthma and COPD Exacerbations

NCT02866357

COPD

COMPLETED

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Acute exacerbations of COPD remain a common cause of morbidity and are associated with a sustained increase in the respiratory symptoms of dyspnoea, cough, sputum volume and sputum purulence. Cough is one of the most commonly reported and key symptoms in COPD patients. Cough can also be a useful factor in finding patients at risk of progressive airflow obstruction and cough along with the breathlessness is the major cause of distress in patients with chronic obstructive airways disease (COPD). There is limited literature looking into cough and COPD especially objective assessments.

in clinical practice and in most clinical trials scoring systems ie quality of life questionnaires or visual analogue scores, have been used to measure COPD exacerbation severity, although these may give an indication of the perceived severity of the symptom, they are inherently subjective and may be influenced by other factors. Shortfalls have prompted the development of cough recorders as an objective measure of this symptom. With this in mind we propose recruit 30 subjects with non-infective exacerbations of COPD and monitor their cough frequency as an inpatient in acute exacerbation and for 45 days post hospital discharge in order to elucidate the natural history of cough during and after an exacerbation.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

COPD Exacerbation

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Observational Model Type

COHORT

Study Time Perspective

PROSPECTIVE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Acute COPD exacerbation

Patients admitted in to hospital with an acute exacerbation of COPD

No interventions assigned to this group

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Male/females aged between 40-80 years.
* Previous diagnosis of COPD.
* Acute exacerbation of COPD requiring treatment with antibiotics and/or corticosteroids.
* Symptoms of increased breathlessness, cough, sputum volume or sputum purulence.
* Acute exacerbation of COPD hospitalised within 48 hrs of study participation.
* On a stable therapeutic regimen for COPD for 8 weeks prior to inclusion.
* Known history of cigarette smoking at least 10 pack yrs.
* Willing and able to comply with study procedures.
* Able to provide written informed consent to participate.

Exclusion Criteria

* Acute exacerbation of COPD within 8 weeks prior to inclusion.
* Clinically significant or unstable concurrent disease e.g. left ventricular failure, diabetes mellitus.
* On long-term oxygen therapy.

Minimum Eligible Age

40 Years

Maximum Eligible Age

80 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No